急诊科尿石症的评估与管理:文献综述
本文综述急诊科尿石症的评估与管理文献。尿石症主要因尿液过饱和形成,常表现为腰痛、血尿和恶心呕吐。病史、查体及实验室检查是评估基石,尿常规不具诊断性但可辅助评估,风险评估工具和先进影像可协助诊断,CT常被视为金标准,低剂量CT可减少辐射,近期研究支持超声作为替代诊断方式(尤其儿童和孕妇)。非甾体抗炎药仍为一线治疗,阿片类或静脉利多卡因用于难治性疼痛;坦索罗辛可增加较大结石的排出但对较小结石未显示获益;不推荐硝苯地平和静脉补液促进排石;手术干预基于结石大小、持续时间和修正因素;出院患者应接受饮食调整建议。
要点
- 非甾体抗炎药仍为急诊尿石症一线治疗,阿片类或静脉利多卡因保留用于难治性疼痛。
- CT常被视为诊断金标准,低剂量CT可减少辐射;超声可作为替代诊断方式,尤其适用于儿童和孕妇。
- 坦索罗辛可增加较大结石的排出,但在较小结石中未显示获益。
- 不推荐使用硝苯地平和静脉补液促进结石排出。
- 手术干预基于结石大小、持续时间和修正因素;出院患者应接受饮食调整建议。
适用人群与场景
- 急诊科就诊的尿石症患者,需镇痛及促进结石排出的治疗。
处置流程与药物剂量
- 非甾体抗炎药仍为一线治疗。
- 阿片类或静脉利多卡因保留用于难治性疼痛。
- 坦索罗辛可用于较大结石以增加排出,但在较小结石中未显示获益。
- 不推荐硝苯地平和静脉补液促进结石排出。
- 手术干预基于结石大小、持续时间和修正因素。
- 出院患者应接受饮食调整建议。
研究设计与关键结果
- 综述总结了急诊科尿石症评估与治疗的当前文献,包括病史、查体、实验室检查、风险评估工具、影像学选项(CT为金标准、低剂量CT减少辐射、超声作为替代尤其儿童和孕妇)及治疗选项(非甾体抗炎药一线、阿片类或静脉利多卡因用于难治性疼痛、坦索罗辛对较大结石增加排出但对较小结石无获益、不推荐硝苯地平和静脉补液促进排石、手术基于结石大小和持续时间及修正因素、出院饮食建议)。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊医生应聚焦病史、查体和实验室检查进行诊断与管理。
- 理解临床特征、风险评估工具、影像学选项和治疗选项可协助急诊医生管理尿石症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Urolithiasis is a common condition in the U.S. Patients frequently present to the emergency department (ED) for care, including analgesia and treatments to facilitate stone passage.
OBJECTIVE: With the new evidence concerning the evaluation and treatment of urolithiasis, this review summarizes current literature regarding the ED management of urolithiasis.
DISCUSSION: Urolithiasis occurs primarily through supersaturation of urine and commonly presents with flank pain, hematuria, and nausea/vomiting. History, examination, and assessment with several laboratory tests are cornerstones of evaluation. Urinalysis is not diagnostic, but it may be used in association with other assessments. Risk assessment tools and advanced imaging can assist with diagnosis. Computed tomography (CT) is often considered the gold standard. Newer low-dose CT imaging may reduce radiation. Recent studies support ultrasound as an alternate diagnostic modality, especially in pediatric and pregnant patients. Nonsteroidal anti-inflammatory drugs remain first-line therapy, with opioids or intravenous lidocaine reserved for refractory pain. Tamsulosin can increase passage in larger stones but has not demonstrated benefit in smaller stones. Nifedipine and intravenous fluids are not recommended to facilitate passage. Surgical intervention is based upon stone size, duration, and modifying factors. Patients who are discharged should be advised on dietary changes.
CONCLUSION: Urolithiasis is a common disease increasing in prevalence with the potential for significant morbidity. Focused evaluation with history, examination, and testing is important in diagnosis and management. Understanding the clinical features, risk assessment tools, imaging options, and treatment options can assist emergency physicians in the management of urolithiasis.
参考来源
- Gottlieb M, Long B, Koyfman A, et al. The evaluation and management of urolithiasis in the ED: A review of the literature. Am J Emerg Med. 2018. PMID: 29321112. doi:10.1016/j.ajem.2018.01.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。